Receptor-Agonist Standards≥ 99.82% HPLC
ARA-290 (10mg) · 10 mg
ARA-290 (10mg) supplied as a laboratory reference material for in-vitro and analytical research.
What it has been studied for
Erythropoietin-derived peptide (cibinetide) studied in nerve and inflammation research.
Human trials: Human clinical trials
Phase 2 human trials completed (small-fiber neuropathy). Not an approved medicine.
Verify the published research
- cibinetide ARA 290: PubMed studies · Human trials registry
Summary of published literature for information only. Not a claim of safety or effectiveness, and not guidance for any use. Research use only — not for human or animal consumption.
Research context
Identity and purity confirmed per lot by third-party HPLC and MS. Research use only — not for human or animal consumption.
Scientific literature
- Lot-matched HPLC purity data
- Mass confirmation by MS
Specifications
- Size
- 10 mg
- Purity
- ≥ 99.82%
- Form
- Lyophilized powder, sealed glass vial
- Storage
- Store lyophilized at -20 °C, protected from light
- Documentation
- Lot-matched HPLC/MS
- Intended Use
- In-vitro research only
We provide no dosing or protocol guidance.